The role of anticoagulant therapy in acute myocardial infarction.
D000925:Anticoagulants / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000503:physiopathology; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D010630:Phenindione / Q000627:therapeutic use; D011655:Pulmonary Embolism / Q000517:prevention & control; D013997:Time Factors; D006113:United Kingdom; D014481:United States; D014493:United States Department of Veterans Affairs; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010630:Phenindione; D014859:Warfarin; D006493:Heparin